#USA #Duluth #Bridge to Life #Liver Transplantation #Pediatric Study

Groundbreaking Global Study on Pediatric Liver Transplantation

In a remarkable advancement for pediatric medicine, a pioneering multicenter study has developed the first international reference framework for pediatric liver transplantation (PLT). Announced during the 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, this study lays crucial groundwork for understanding morbidity, complications, transplant survival rates, and recipient outcomes across diverse pediatric transplant populations worldwide.

The Study's Overview

The study, led by Dr. Sapana Verma, MD, PhD, under the mentorship of Professor Andrea Schlegel from the Cleveland Clinic, assessed primary pediatric liver transplants conducted between 2000 and 2024 in nine significant transplantation centers across North America, Asia, Europe, South America, and Africa/Middle East. With the comprehensive analysis, this research addresses a long-standing gap in pediatric transplantation — the absence of standardized outcome measures necessary for assessing transplant selection, risk stratification, and post-transplant quality evaluation.

Dr. Verma emphasizes, "Globally recognized benchmark standards for pediatric liver transplantation have been lacking. Our objective was to establish international reference standards for morbidity and survival rates after pediatric liver transplantation and to create a data-driven framework for transplant selection across heterogeneous pediatric subgroups."

Key Findings

The benchmark cohort revealed significantly lower primary morbidity, along with fewer kidney, vascular, and biliary complications, and shorter intensive care unit and hospital stays. Notably, the benchmarking model enabled robust differentiation of outcomes in varied pediatric populations, providing a scalable platform for future global quality assessment and risk-adjusted outcome analyses.

The study has also proposed expanding its work to encompass a multicenter cohort of more than 10,000 recipients to establish definitive global reference standards and validate outcome thresholds based on age, weight, liver disease etiology, transplant type, and combined risk profiles of recipients.

Importance for Pediatric Transplantation

This groundbreaking research is pivotal as it fills a critical void in pediatric transplantation, offering a set of standardized reference points akin to those available in adult transplantation. Don Webber, President and CEO of Bridge to Life Ltd, notes, "As the field progresses towards precise transplant evaluations, viability assessments, and optimized preservation strategies, such as hypothermic oxygen perfusion (HOPE), robust benchmark standards become essential. These reference standards not only define what success looks like but also enhance access to safe transplants for a greater number of pediatric patients globally."

The study made use of the VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) system developed by Bridge to Life, highlighting its safety and effectiveness in pediatric liver transplantation and affirming the growing significance of machine perfusion and viability-oriented decision-making in this specialized patient group.

A Foundation for Future Clinical Decisions

With pediatric transplantation shifting toward personalized transplant selection and broader adoption of advanced preservation technologies, the newly established benchmark standards serve as a vital foundation for the next generation of clinical decision-making. While benchmarking defines achievable goals, advanced preservation strategies such as HOPE may provide promising pathways to improve high-risk transplant outcomes closer to benchmark results.

About Bridge to Life™ Ltd

Bridge to Life™ Ltd stands at the forefront of innovation in organ preservation technologies and solutions, offering premium products like Belzer UW®, EasiSlush®, and the VitaSmart™ Hypothermic Oxygenated Perfusion System. Focused on product quality, innovation, and accessibility, the company collaborates globally with leading transplant centers and organ procurement organizations to improve outcomes for transplant patients worldwide.